Pluri Inc. Receives Nasdaq Delisting Notice for Failing Minimum Market Value Requirement
PLUR sits 17% above its 52-week low of $2.82.
Summary
Pluri Inc. received a Nasdaq delisting notice for failing to meet the minimum $35 million market value of listed securities requirement, with a 180-day period to regain compliance.
Key Events · Corporate Governance and Compliance · PLUR
-
Nasdaq Delisting Notice Received
On January 20, 2026, Pluri Inc. received a notice from Nasdaq indicating non-compliance with Listing Rule 5550(b)(2), which requires a minimum of $35 million in market value of listed securities (MVLS).
-
Failure to Meet Alternative Standards
The company also failed to meet alternative listing standards, including having stockholders' equity of at least $2.5 million or net income of $500,000.
-
180-Day Compliance Period
Pluri Inc. has been granted an initial period of 180 calendar days, until July 20, 2026, to regain compliance. This requires its MVLS to close at $35 million or more for a minimum of 10 consecutive business days.
-
No Immediate Effect on Trading
The notice has no immediate impact on the listing or trading of the company's common shares, which will continue to trade on The Nasdaq Capital Market under the symbol 'PLUR'.
Analysis · PLUR · Life Sciences
Pluri Inc. has received a critical notice from Nasdaq regarding its non-compliance with the minimum market value of listed securities (MVLS) requirement. The company's current market capitalization falls below the $35 million threshold, and it also fails to meet alternative listing standards. While there is a 180-day grace period to regain compliance, the company faces a significant challenge to increase its market value sufficiently. Failure to do so could lead to delisting, which would severely impact the stock's liquidity and investor confidence. Investors should monitor the company's actions and progress towards regaining compliance closely, as delisting would be a major negative event.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLUR was trading at $3.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.4M. The 52-week trading range was $2.82 to $7.13. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.